AI Science Tracker
EN

Development and validation of venous thrombosis risk prediction model and scale for lung cancer patients in intensive care unit based on interpretable machine learning.

Affiliation not stated in the reviewed material · 28 Aug 2026 · medicine

Discovery

Development and validation of venous thrombosis risk prediction model and scale for lung cancer patients in intensive care unit based on interpretable machine learning.

Source check: Source checked. Not independent scientific confirmation.

Finding: An interpretable model predicted venous-thrombosis risk among lung-cancer patients in ICU.

Technology: Boruta, variance-inflation analysis and LASSO screened predictors; nine models, including CatBoost, estimated ICU venous-thromboembolism risk, with SHAP interpretation and a score derived from the best model.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Boruta, variance-inflation analysis and LASSO screened predictors; nine models, including CatBoost, estimated ICU venous-thromboembolism risk, with SHAP interpretation and a score derived from the best model.
Test and result
In 3,694 ICU records across MIMIC-IV, eICU and NWICU, CatBoost AUCs were 0.7648 in training, 0.6437 in internal validation, 0.6822 in eICU and 0.7153 in NWICU. This retrospective prediction does not establish clinical benefit.
Limitation / still unknown
The cohort is drawn from existing ICU databases; reported validation AUCs are modest (0.64–0.72), and no prospective clinical-impact evaluation is reported.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13559455/ · https://europepmc.org/article/MED/42724662

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.